On the heels of news that Dan Uggla rejected a four-year, $48 million offer, MLB.com’s Joe Frisaro — after confirming the offer Rosenthal mentioned — reports that the Marlins “may seriously consider” trading him.
He’d be valuable to any number of teams, I presume. But maybe less so if they think that he wants a deal of five years or greater than $48 million from them too. Ultimately, it seems, the true gauge of Uggla’s trade value is whether he just wants out of Miami for some reason or if he truly thinks he’s worth Chase Utley money or something close to it.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.